FDA’s new device chief faces challenges. Patient groups, industry are still optimistic.

FDA’s new device chief faces challenges. Patient groups, industry are still optimistic.

Source: 
BioPharma Dive
snippet: 

Patient advocates are hoping for change under new director Michelle Tarver, while industry groups hope she will build on former director Jeff Shuren’s leadership.